What We Do
PsiOxus aims to be the world’s leading company in tumour re-engineering, delivering medicines of value to patients with cancer.
PsiOxus is a clinical stage company pioneering systemic oncology products that drive reprogramming of the tumor microenvironment to overcome the central challenge of resistance to therapy. We have a rapidly expanding pipeline of novel monotherapy and combination products to dramatically improve outcomes for patients with cancer.
Target audience: Medical professionals and patients